(Q59194538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Effect of Recombinant Alpha Interferon on NK and ADCC Function in Lung Cancer Patients: Results from a Phase II Trial (English)

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

3 August 2023

main subject

immunology

0 references

phase II clinical trial

1 reference

P. Hokland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6094685

3 August 2023

M. Hokland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6094685

3 August 2023

B. K. Olesen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6094685

3 August 2023

P. Ernst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6094685

3 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6094685

3 August 2023

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

26 October 2019

http://www.liebertpub.com/doi/pdf/10.1089/jir.1984.4.561

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

Journal of Interferon Research

3 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

561-569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6094685%20AND%20SRC:MED&resulttype=core&format=json

Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon

26 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

Effect of Leucocyte Interferon on Natural Killer Cells in Healthy Volunteers

3 August 2023

2

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

Effect of interferon-alpha 1 from E. coli on some cell functions.

3 August 2023

4

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

Induction and kinetics of natural killer cells in humans following interferon therapy

3 August 2023

8

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer

3 August 2023

9

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561

Interferon-Induced Changes in Expression of Antigens Defined by Monoclonal Antibodies on Malignant and Nonmalignant Mononuclear Hematopoietic Cells

3 August 2023

13

1 reference

https://api.crossref.org/works/10.1089/JIR.1984.4.561